N/A Completed N=105 Randomized Treatment

Mopati: A Pilot Hiv Treatment Partner Intervention In Botswana

HIV

Source: ClinicalTrials.gov NCT04796610 ↗

Enrolled (actual)

105

Serious AEs

0.0%

Results posted

Nov 2023

Primary outcomePrimary: Viral Suppression of Patient Participants — 12; 13 Participants — p=0.49

Summary

This study is a pilot test of the Mopati program ("partner" in Setswana), which is a multi-level intervention that guides healthcare providers and patients about treatment partner selection, and trains treatment partners on provision of effective support. The Specific Aims are: (1) To develop a multi-level treatment partner intervention with input from community and healthcare provider stakeholders in Botswana; and (2) To conduct a pilot test of the feasibility, acceptability, and preliminary effects on viral suppression.

Outcome Measures

Outcome	Result	p-value
PRIMARY Viral Suppression of Patient Participants	12; 13	0.49
SECONDARY Number of Patient Participants Self-Reported as Treatment Adherent	24; 22	.011 sig
SECONDARY Perceived Treatment Partner Support	4.9; 4.5	.03 sig

Eligibility Criteria

Inclusion Criteria

Patients will be eligible if they are: 1) 18 years of age or older, 2) On antiretroviral treatment for HIV (ART) and initiated ART at least 6 months prior, and 3 ) Not virally suppressed (one viral load ≥ 400 cp/ml within prior 12 months at time of enrollment).
Treatment partners will be eligible if they are 18 years of age or older and selected to be a patient's treatment partner.

Exclusion Criteria

Patients will not be eligible if they screen positive for HIV-related dementia or if they show ART resistance.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04796610). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.